These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 16309241

  • 1. Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.
    Erjala K, Raitanen M, Kulmala J, Grénman R.
    Anticancer Res; 2005; 25(6B):4363-7. PubMed ID: 16309241
    [Abstract] [Full Text] [Related]

  • 2. Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro.
    Erjala K, Pulkkinen J, Kulmala J, Grénman R.
    Acta Oncol; 2004; 43(2):169-74. PubMed ID: 15163165
    [Abstract] [Full Text] [Related]

  • 3. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
    Erjala K, Pulkkinen J, Kulmala J, Alanen K, Grenman R.
    Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
    [Abstract] [Full Text] [Related]

  • 4. Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro.
    Erjala K, Zhang N, Sundvall M, Kulmala J, Elenius K, Grénman R.
    Radiother Oncol; 2007 Oct; 85(1):138-45. PubMed ID: 17923163
    [Abstract] [Full Text] [Related]

  • 5. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.
    Erjala K, Raitanen M, Kulmala J, Grénman R.
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904
    [Abstract] [Full Text] [Related]

  • 6. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
    Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R.
    Anticancer Res; 1997 Mar; 17(2A):939-43. PubMed ID: 9137431
    [Abstract] [Full Text] [Related]

  • 7. Ex vivo responsiveness of head and neck squamous cell carcinoma to vinorelbine.
    Dollner R, Granzow C, Tschop K, Dietz A.
    Anticancer Res; 2006 Mar; 26(3B):2361-5. PubMed ID: 16821617
    [Abstract] [Full Text] [Related]

  • 8. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
    Ngan VK, Bellman K, Panda D, Hill BT, Jordan MA, Wilson L.
    Cancer Res; 2000 Sep 15; 60(18):5045-51. PubMed ID: 11016627
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck.
    Jääskelä-Saari HA, Kairemo KJ, Jekunen AP, Pekkola-Heino K, Kulmala J, Ramsay HA, Grenman R.
    Cancer Detect Prev; 1996 Sep 15; 20(4):279-84. PubMed ID: 8818387
    [Abstract] [Full Text] [Related]

  • 10. Endometrial cancer cell lines are sensitive to paclitaxel.
    Rantanen V, Grénman S, Kulmala J, Grénman R.
    Anticancer Res; 1996 Sep 15; 16(1):475-9. PubMed ID: 8615657
    [Abstract] [Full Text] [Related]

  • 11. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C, Brichese L, Barret JM, Tollon Y, Kruczynski A, Hill BT, Wright M.
    Anticancer Drugs; 1999 Jul 15; 10(6):537-43. PubMed ID: 10885901
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
    Lei XS, Yu XD, Yin L, Liu ZH, Tang PC.
    Bioorg Med Chem Lett; 2008 Aug 15; 18(16):4602-5. PubMed ID: 18653334
    [Abstract] [Full Text] [Related]

  • 13. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
    Mandic R, Rodgarkia-Dara CJ, Krohn V, Wiegand S, Grénman R, Werner JA.
    Anticancer Res; 2009 Apr 15; 29(4):1181-7. PubMed ID: 19414362
    [Abstract] [Full Text] [Related]

  • 14. Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.
    Simoens C, Vermorken JB, Korst AE, Pauwels B, De Pooter CM, Pattyn GG, Lambrechts HA, Breillout F, Lardon F.
    Cancer Chemother Pharmacol; 2006 Aug 15; 58(2):210-8. PubMed ID: 16317558
    [Abstract] [Full Text] [Related]

  • 15. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A, Colpaert F, Tarayre JP, Mouillard P, Fahy J, Hill BT.
    Cancer Chemother Pharmacol; 1998 Aug 15; 41(6):437-47. PubMed ID: 9554586
    [Abstract] [Full Text] [Related]

  • 16. A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity.
    Lobert S, Ingram JW, Hill BT, Correia JJ.
    Mol Pharmacol; 1998 May 15; 53(5):908-15. PubMed ID: 9584218
    [Abstract] [Full Text] [Related]

  • 17. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA, Tsvetkov PO, Villard C, Esquieu D, Pourroy B, Fahy J, Braguer D, Peyrot V, Lafitte D.
    Biochemistry; 2007 Dec 25; 46(51):14899-906. PubMed ID: 18052208
    [Abstract] [Full Text] [Related]

  • 18. Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.
    Simoens C, Pauwels B, Vermorken JB, Pattyn GG, Lambrechts HA, Breillout F, Lardon F.
    Cancer Chemother Pharmacol; 2008 Jul 25; 62(2):183-93. PubMed ID: 17899084
    [Abstract] [Full Text] [Related]

  • 19. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT.
    Biochem Pharmacol; 1998 Mar 01; 55(5):635-48. PubMed ID: 9515574
    [Abstract] [Full Text] [Related]

  • 20. Head and neck squamous cell carcinoma cell lines are highly sensitive to the new taxanes, BMS-184476, BMS-188797, in vitro.
    Raitanen M, Pulkkinen J, Kulmala J, Grénman R.
    Anticancer Res; 2004 Mar 01; 24(6):3769-73. PubMed ID: 15736410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.